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The conclusion section should read as:
Our results show that the continuous intake of ART for 4 weeks in doses up to 200 mg daily was well tolerated concerning neuro-audiological function at all three doses tested in patients with metastatic or locally advanced breast cancer. However, a temporary dose-limiting vertigo was observed, two patients experienced ongoing subclinical hearing loss and another one an ongoing tinnitus. Therefore, regular audiological assessments should be included in clinical studies investigating oral ART in the treatment of cancer patients.
